Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News GSK American Depositary Shares Representing 2 Ordinary Shares GSK

Consumer Cyclical

GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with... see more

Add To Watchlist

Recent & Breaking News (NYSE:GSK)

GSK announces FDA advisory committee votes in favour of positive benefit/risk profile for belantamab mafodotin for patients with relapsed/refractory multiple myeloma

PR Newswire July 14, 2020

GSK Consumer Healthcare teams up with Paula Abdul for the launch of Voltaren Arthritis Pain Gel

PR Newswire June 11, 2020

GSK partners with Samsung Biologics to secure additional manufacturing capacity for innovative biopharmaceutical portfolio

PR Newswire May 21, 2020

Identification and Characterization of a Potential Therapeutic COVID-19 Antibody by Vir Biotechnology Published in Nature

GlobeNewswire May 18, 2020

FDA approves Zejula (niraparib) as the only once-daily PARP inhibitor in first-line monotherapy maintenance treatment for women with platinum-responsive advanced ovarian cancer regardless of biomarker status

PR Newswire April 29, 2020

GSK Presents New Data from the GARNET Study Demonstrating Potential of Dostarlimab to Treat a Subset of Women with Recurrent or Advanced Endometrial Cancer

Business Wire April 23, 2020

Voltaren Arthritis Pain and the Arthritis Foundation Announce Multi-Year Partnership to Help People Living with Osteoarthritis

PR Newswire April 13, 2020

GSK and Vir Biotechnology enter collaboration to find coronavirus solutions

GlobeNewswire April 6, 2020

FDA approves GSK's Advil Dual Action with Acetaminophen for over-the-counter use in the United States

PR Newswire February 28, 2020

FDA approves GSK's Voltaren Arthritis Pain for over-the-counter use in the United States

PR Newswire February 17, 2020

TUMS game day sweepstakes

PR Newswire January 28, 2020

GSK Announces U.S. Food and Drug Administration Approval of Additional Indication for Zejula (niraparib) for Late-line Treatment for Women with Recurrent Ovarian Cancer

Business Wire October 23, 2019

GSK Submits Filing to FDA for Trelegy Ellipta Use in Patients With Asthma

Business Wire October 2, 2019

GSK presents new data showing promising anti-tumour activity with GSK3359609, an ICOS receptor agonist, in combination with pembrolizumab in head and neck squamous cell carcinoma (HNSCC)

PR Newswire September 28, 2019

Nucala is the first biologic approved in the US for six to 11-year-old children with severe eosinophilic asthma

Business Wire September 12, 2019

Nucala (mepolizumab) Gains FDA Approval for Two New Self-Administration Options

Business Wire June 6, 2019

The Daily Biotech Pulse: PhaseBio Gets Breakthrough Therapy Designation, FDA Shoots Down Zogenix Epilepsy Regulatory Filing

Benzinga.com April 9, 2019

Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates

Benzinga.com March 29, 2019

Markets React Amid Report FDA Commish Scott Gottlieb Will Resign

Benzinga.com March 5, 2019

Q4 Earnings Outlook For GlaxoSmithKline

Benzinga.com February 5, 2019